| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.17 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |